Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities

Podobne zapisy

• Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities
  od: Affer, M., i wsp.
  Wydane: (2011)
• Biophysical Differences between Chronic Myelogenous Leukemic Quiescent and Proliferating Stem/Progenitor Cells
  od: Guz, Nataliia V., i wsp.
  Wydane: (2016)
• Further phenotypic characterization of the primitive lineage− CD34+CD38−CD90+CD45RA− hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia
  od: Wisniewski, D, i wsp.
  Wydane: (2011)
• Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells
  od: Welner, Robert S., i wsp.
  Wydane: (2015)
• Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
  od: Verfaillie, C M, i wsp.
  Wydane: (1992)